Medica Sur SA de CV

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MXP510121215
MXN
56.00
-1.42 (-2.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -9.42% of over the last 5 years

 
2

The company declared negative results in Jun'26 after flat results in Mar'26

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

MXN 6,846 Million (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.02%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

20.04%

stock-summary
Price to Book

2.58

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2026)
Net Profit:
118 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.27%
0%
-4.27%
6 Months
-3.45%
0%
-3.45%
1 Year
24.44%
0%
24.44%
2 Years
62.32%
0%
62.32%
3 Years
33.33%
0%
33.33%
4 Years
0.02%
0%
0.02%
5 Years
22.3%
0%
22.3%

Medica Sur SA de CV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.77%
EBIT Growth (5y)
-9.42%
EBIT to Interest (avg)
8.24
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.32
Tax Ratio
32.05%
Dividend Payout Ratio
23.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.25%
ROE (avg)
16.72%

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.47
EV to EBIT
7.61
EV to EBITDA
6.04
EV to Capital Employed
2.99
EV to Sales
1.23
PEG Ratio
0.61
Dividend Yield
0.02%
ROCE (Latest)
39.30%
ROE (Latest)
20.04%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -100.00% vs -2.29% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -12.49% vs -2.89% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "1,194.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "242.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "25.40",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.70",
          "val2": "134.50",
          "chgp": "-12.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "160.50%",
          "chgp": "-16.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.77% vs 6.61% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 27.86% vs -24.27% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,788.90",
          "val2": "4,402.80",
          "chgp": "8.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,040.20",
          "val2": "882.30",
          "chgp": "17.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "163.20",
          "val2": "123.80",
          "chgp": "31.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "-74.40",
          "chgp": "101.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "540.20",
          "val2": "422.50",
          "chgp": "27.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "175.40%",
          "val2": "156.30%",
          "chgp": "1.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
0.00
1,194.70
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
242.20
-100.00%
Interest
0.00
25.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
117.70
134.50
-12.49%
Operating Profit Margin (Excl OI)
0.00%
160.50%
-16.05%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -100.00% vs -2.29% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -12.49% vs -2.89% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
4,788.90
4,402.80
8.77%
Operating Profit (PBDIT) excl Other Income
1,040.20
882.30
17.90%
Interest
163.20
123.80
31.83%
Exceptional Items
0.80
-74.40
101.08%
Consolidate Net Profit
540.20
422.50
27.86%
Operating Profit Margin (Excl OI)
175.40%
156.30%
1.91%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 8.77% vs 6.61% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 27.86% vs -24.27% in Dec 2024

stock-summaryCompany CV
About Medica Sur SA de CV stock-summary
stock-summary
Medica Sur SA de CV
Pharmaceuticals & Biotechnology
Medica Sur SAB de CV is a Mexico-based company primarily engaged in the healthcare sector. The Company manages hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, as well as an accommodation place. It provides medical services within various specializations, such as anatomic pathology, cardiology, gynecology and obstetrics, neonatology, neurophysiology, odontology, oncology, ophthalmology, orthopedics, otolaryngology, pediatrics, radiology and imaging, as well as radiosurgery. In addition, the Company offers medical tourism services and distributes drugs. It forms a part of Mayo Clinic Care Network. The Company operates through a range of subsidiaries, such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV and Telemed SA de CV. The Company is owned by Neuco SA de CV.
Company Coordinates stock-summary
Company Details
Puente de Piedra 150, Col. Toriello Guerra TLALPAN None : 14050
stock-summary
Tel: 52 55 5424720052 5 4247200
stock-summary
Registrar Details